•the Covid excuse needs to be buried •who cares the exact reason Board removed former ceo •the company has been clear why TGA application was withdrawn, doesn’t need further discussion. •you can replace the board as many times as you like and hire all the SrX people you want but it doesn’t change the one problem that trumps all other issues, which is the current evidence from their main trial isn’t strong enough to convincingly show benefit of device and until that’s solved this will be very tough to commercialise. •imo it’s likely CE mark award was borderline and just tipped finally in their favour but this looks hard slog and won’t change without more evidence for the device from bigger rigorous trials. And the majority of the market recognises this which is why it’s 5 cents.
OSL Price at posting:
5.0¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)